Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WILLIAM A HANDELMAN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1609851369
CMS profile
437557
Location
TORRINGTON, CT

General Payments · PY2018–2024

$3,071.24

  • Reported across 134 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$748.47

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $731.58 36
Education $16.89 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $416.23 19
PY2019 $466.57 19
PY2020 $105.99 5
PY2021 $309.56 10
PY2022 $565.69 20
PY2023 $458.73 24
PY2024 $748.47 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $16.85 08/06/2024 Food and Beverage Undisputed 01/23/2026 1093884331 CMS
Amgen Inc. $34.57 04/02/2024 Food and Beverage Undisputed 01/23/2026 1117572409 CMS
Amgen Inc. $13.42 04/12/2024 Food and Beverage Undisputed 01/23/2026 1115699210 CMS
Amgen Inc. $21.72 06/28/2024 Food and Beverage Undisputed 01/23/2026 1115699226 CMS
Amgen Inc. $18.10 07/19/2024 Food and Beverage Undisputed 01/23/2026 1115699218 CMS
Amgen Inc. $17.97 11/08/2024 Food and Beverage Undisputed 01/23/2026 1115699234 CMS
Amgen Inc. $26.47 12/10/2024 Food and Beverage Undisputed 01/23/2026 1117572411 CMS
Ardelyx, Inc. $14.30 04/23/2024 Food and Beverage Undisputed 01/23/2026 1146683949 CMS
Ardelyx, Inc. $17.16 08/13/2024 Food and Beverage Undisputed 01/23/2026 1146683951 CMS
AstraZeneca Pharmaceuticals LP $13.33 01/23/2024 Food and Beverage Undisputed 01/23/2026 1104333752 CMS
AstraZeneca Pharmaceuticals LP $13.94 07/30/2024 Food and Beverage Undisputed 01/23/2026 1104661161 CMS
AstraZeneca Pharmaceuticals LP $18.00 10/01/2024 Food and Beverage Undisputed 01/23/2026 1104213109 CMS
Aurinia Pharma U.S., Inc. $22.58 05/28/2024 Food and Beverage Undisputed 01/23/2026 1150681555 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.21 05/07/2024 Food and Beverage Undisputed 01/23/2026 1086232600 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.25 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118079200 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.18 04/26/2024 Food and Beverage Undisputed 01/23/2026 1118079202 CMS
Fresenius USA Marketing, Inc. $21.33 11/26/2024 Food and Beverage Undisputed 01/23/2026 1154211090 CMS
Lilly USA, LLC $21.39 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135483063 CMS
Lilly USA, LLC $14.95 11/25/2024 Food and Beverage Undisputed 01/23/2026 1135470357 CMS
Mallinckrodt Hospital Products Inc. $38.18 02/07/2024 Food and Beverage Undisputed 01/23/2026 1145080949 CMS
Medtronic, Inc. $16.63 04/19/2024 Food and Beverage Undisputed 01/23/2026 1119400384 CMS
Novartis Pharmaceuticals Corporation $13.66 05/14/2024 Food and Beverage Undisputed 01/23/2026 1086954131 CMS
Novartis Pharmaceuticals Corporation $33.05 09/03/2024 Food and Beverage Undisputed 01/23/2026 1086954107 CMS
Novartis Pharmaceuticals Corporation $31.37 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086954127 CMS
Novo Nordisk Inc $24.94 08/27/2024 Food and Beverage Undisputed 01/23/2026 1097306975 CMS
Novo Nordisk Inc $23.18 10/15/2024 Food and Beverage Undisputed 01/23/2026 1096845164 CMS
Otsuka America Pharmaceutical, Inc. $18.51 02/02/2024 Food and Beverage Undisputed 01/23/2026 1118904681 CMS
Otsuka America Pharmaceutical, Inc. $15.65 06/04/2024 Food and Beverage Undisputed 01/23/2026 1118904683 CMS
Otsuka America Pharmaceutical, Inc. $17.90 12/03/2024 Food and Beverage Undisputed 01/23/2026 1118904685 CMS
PFIZER INC. $19.48 02/23/2024 Food and Beverage Undisputed 01/23/2026 1131081110 CMS
PFIZER INC. $18.32 07/09/2024 Food and Beverage Undisputed 01/23/2026 1131765216 CMS
Travere Therapeutics, Inc. $15.17 01/30/2024 Food and Beverage Undisputed 01/23/2026 1149915481 CMS
Travere Therapeutics, Inc. $16.89 01/30/2024 Education Undisputed 01/23/2026 1149915485 CMS
Travere Therapeutics, Inc. $23.35 05/21/2024 Food and Beverage Undisputed 01/23/2026 1149915489 CMS
Travere Therapeutics, Inc. $4.00 08/19/2024 Food and Beverage Undisputed 01/23/2026 1149915477 CMS
Travere Therapeutics, Inc. $25.46 08/19/2024 Food and Beverage Undisputed 01/23/2026 1149915493 CMS
Xeris Pharmaceuticals, Inc. $20.01 11/01/2024 Food and Beverage Undisputed 01/23/2026 1144617527 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.